Cargando…
The efficacy of Ankaferd Blood Stopper(®) in an experimental Asherman syndrome model created in rats
OBJECTIVE: Asherman syndrome (AS) is a progressive disease involving menstrual disorders, recurrent pregnancy losses, and infertility developing as a result of partial or full blockade of the uterine cavity with adhesions. AS generally develops after trauma to the basal layer of the endometrium. In...
Autores principales: | Büyük, Başak, Beyazıt, Fatma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463422/ https://www.ncbi.nlm.nih.gov/pubmed/31019834 http://dx.doi.org/10.4274/tjod.galenos.2018.21298 |
Ejemplares similares
-
Successful Application of Ankaferd Blood Stopper in a Patient with Lower Gastrointestinal Bleeding
por: Beyazit, Yavuz, et al.
Publicado: (2011) -
Effect of ankaferd blood stopper in experimental peritoneal adhesion model
por: Karaca, Gokhan, et al.
Publicado: (2016) -
Experimental Investigation of the Effects of a Blood Stopper Agent (Ankaferd Blood Stopper) on Bone Surfaces
por: Şimşek, Hasan Onur, et al.
Publicado: (2013) -
Histopathological and mechanical effects of Ankaferd Blood Stopper® on wound healing in rats: an experimental model
por: HANCIOĞLU, Sertaç, et al.
Publicado: (2020) -
Assessment of Ankaferd Blood Stopper in experimental liver ischemia reperfusion injury
por: DURHAN, Abdullah, et al.
Publicado: (2020)